about
Comparison of utilization of cardiovascular drugs in the Czech Republic and in WalesDiabetes mellitus cerebrovascular diseaseTherapeutic use of acetylsalicylic acid in diabeticsEffect of beta radiation brachytherapy in the treatment of restenosis of coronary stentsIncrease in troponin levels after coronary angioplasty (PTCA) in stable angina pectorisUse of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complicationsInitial experience with use of cationic propyl gallate as an inducer of thrombocyte aggregation in evaluation of anti-aggregation therapyDirect percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective studyAcetylsalicylic acid and ACE inhibitors in heart disease--a phenomenon in dogs and cats?Acetylsalicylic acid--is everything clear? Probably notGlycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplastyAcetylsalicylic acid (ASA)--is everything clear?Atherosclerotic nephropathy in renal artery stenosis--from randomized studies to individualized therapyPrevention of venous thromboembolism: generally accepted guidelinesPrevention of venous thromboembolism in surgery, in laparoscopic surgery, in venous surgery and in urologyPrevention of venous thromboembolism in orthopaedicsPrevention of venous thromboembolism in internal medicine and neurologyGastroduodenal complications associated with non-steroidal anti-inflammatory drugs in Slovak Republic: results of one-year prospective studyAssessment of speed of an anti-platelet effect after two different doses of acetylsalicylic acid by flocculationClinical importance of aspirin resistanceThe prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practiceClinically manifest gastrointestinal bleeding in patients subject to coronary angiographyCombination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phaseIntravenous systemic thrombolysis using streptokinase in the treatment of developing cardiogenic shock in myocardial infarctTesting the effectiveness of drug therapy in supraventricular dysrhythmias using diagnostic esophageal cardiac stimulationMulticenter study of isradipine in the treatment of hypertensionHemodynamic effect of mesocaine and ajmaline in acute myocardial infarctIntrahepatic cholestasis following ketazone successfully treated using the enzyme inductor phenobarbital[Treatment of elderly diabetic patients].[Impact of pandemic H1N1 2009 influenza virus on critical care in Australia: a single centre case series][Management of type 2 diabetes mellitus therapy in a mature age].Obesity and atherosclerosis--what's the link?[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].[Dyslipidemia and obesity 2011. Similarities and differences].[Dr. Václav Baudis, M.D.--obituary].[Predatory journals: how their publishers operate and how to avoid them].[Unusual musical diastolic murmur in aortic regurgitation][Pathographic study of Leos Janácek].[Thoughts on Frederic Chopin's illness].[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
P1433
Q28165507-ECDA09BE-2AE5-47C4-8251-8B6281BE7001Q28167991-315DFC90-781E-41FA-8AB1-1328C3798F29Q28167992-C96AB9CE-4D7E-41C8-A1A5-6B0901CD4CEBQ28168184-179186F3-96CC-4393-8C97-ED52B067EB1FQ28168511-60784C88-C8FB-42BF-A894-23873164C004Q28171381-F7F0234D-957C-4B8F-B7EF-71AC9476F4B9Q28192144-FE18F595-C960-4617-AABD-049D4B25C870Q28193181-1A66B2BA-09F7-4ECF-9BA6-988E0EDC10CCQ28194157-E99FF941-ADE6-4357-ACCD-34589E03CB9FQ28194158-C841EA21-7254-4035-93AA-ECBCC6E2C15AQ28194159-B265D7AF-7C2C-4FE2-809D-06F96FFA77D2Q28194161-924D52DB-75C8-460C-8E4F-9DD5B6517E74Q28195838-C345F76D-2824-4689-922F-59B6F05FA376Q28196735-5498683D-04D5-44C3-9CB1-8C6349B2D3B7Q28196739-4AE26EA2-EC33-41FA-A5BD-6FE0D82F5C49Q28196742-689B58CA-344E-4880-BB95-8376254F2573Q28196744-C7162A68-7CBA-4CD1-BE73-3D0FC7CA768DQ28200467-C72734CD-4E8F-4BD7-963D-FE1358BC7A10Q28212281-2414ED8E-3898-45BC-B0E0-4CA429E23A24Q28212293-C5B4BBF7-284C-402B-A7AE-EFC0CEE05DC9Q28218841-BFDA3E0B-C70E-4F03-A131-F6D082513B66Q28222177-6C8CA7DB-9F2C-4F8C-AC97-1F0F2E9298B8Q28273049-A8C5C69A-FF6F-4A37-9FC6-DF92F34494AEQ28292350-9ACF20E5-357F-40C0-9F5D-FCB8E74A43CEQ28325335-82FF6F71-DB3B-47E7-BE56-FAB149FDFB7BQ28327594-75A1252E-1B3B-4935-B63F-18F9BACB80FFQ28328196-D6CB48AB-618E-44A5-89AD-BB2EA0BFED73Q28330032-C903B534-51C6-4E15-BB63-7FBB79F1DA81Q30373956-DA35C022-2580-4BD0-AA2F-F79340848D96Q30384344-68A6ED0A-03FF-4677-AEFF-277A55C9EFEAQ30388098-EB6A7E51-0AFD-4EB8-AF73-D2DFD47A70A7Q30389081-2CB24F7C-D4D1-4687-A032-1ED7E50F4FD6Q30397956-588C68B2-BC9D-4ECE-B954-9FEB4C1EDECBQ30401882-2AF87063-8EA6-4083-B2D3-437C356C1935Q30409588-BC0C0672-10E9-43C9-9A57-EF099128EEC5Q30490936-8C650000-6CA9-483E-80E5-2F2F4CDA0B9DQ30528004-58E51BAE-6BDC-4846-B172-85A9B913D617Q30536187-6640810D-3B00-45D8-A45D-12F287645815Q30536394-2053E3A1-7040-4259-A0B1-C40A9111D7D9Q30582579-C9FFA198-679E-440F-A571-F99374F1B7C5
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Vnitrni lekarstvi
@ast
Vnitrni lekarstvi
@en
Vnitrni lekarstvi
@es
Vnitrni lekarstvi
@it
Vnitrni lekarstvi
@nl
type
label
Vnitrni lekarstvi
@ast
Vnitrni lekarstvi
@en
Vnitrni lekarstvi
@es
Vnitrni lekarstvi
@it
Vnitrni lekarstvi
@nl
altLabel
Vnitr Lek
@en
prefLabel
Vnitrni lekarstvi
@ast
Vnitrni lekarstvi
@en
Vnitrni lekarstvi
@es
Vnitrni lekarstvi
@it
Vnitrni lekarstvi
@nl
P1055
P1156
P1476
Vnitrni lekarstvi
@en